ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Global Trial for COVID-19 Vaccine Begins at NYU Langone Health americanpharmaceuticalreview
August 04, 2020The first U.S. patients are being dosed in a Phase 2/3 clinical trial testing whether a messenger RNA (mRNA) vaccine candidate can prevent infection with the virus that causes 2019 coronavirus disease (COVID-19).
Pharma Sources Insight January 2025
